IBRX logo
ImmunityBio, Inc.(IBRX)
Last print unknown agoAbout this dataData status
$8.42▼-0.76 (-8.28%)Stale · unknown oldEarnings · Nov 3

IBRX CapEx to Revenue

4.45%TTM

Retrieved:

IBRX FY CapEx/Revenue%
IBRX FY CapEx/Revenue86650.61%-9283.44%
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

IBRX capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Immunitybio Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.3949%
46.7141%
4,917.0418%
32,567.5%
3,593.469%
275.8678%
9,969.7674%
27,876.5957%
77,366.6667%
14,909.0909%
949.5763%
46.6459%
0.5%

Compare capex to revenue

All IBRX financial metrics · IBRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.